Baselake Partners, LP Fully Exits Position in Kezar Life Sciences, Inc. (KZR)

On May 28, 2026, Baselake Partners, LP, Baselake Management, LLC, and David Paolella filed an amendment to their Schedule 13G regarding Kezar Life Sciences, Inc. (KZR). The filing indicates that the reporting persons have fully exited their position in the company's common stock. As of the event date of May 11, 2026, the filers reported owning zero shares, representing 0.0% of the class. This filing serves as an exit statement, noting that the reporting persons have ceased to be the beneficial owners of more than five percent of the issuer's common stock. The reporting entities, based in Troy, Michigan, confirmed that the securities were not held for the purpose of changing or influencing the control of the issuer. David Paolella signed the filing in his capacity as Managing Member of Baselake Management, LLC (the investment manager for Baselake Partners, LP) and individually.